Defining outcomes for beta cell replacement therapy: a work in progress

Lorenzo Piemonti, Eelco J P de Koning, Thierry Berney, Jon S Odorico, James F Markmann, Peter G Stock, Michael R Rickels

Onderzoeksoutput: Bijdrage aan wetenschappelijk tijdschrift/periodieke uitgaveArtikelWetenschappelijkpeer review

Samenvatting

Defined outcomes for beta cell replacement therapy in the treatment of diabetes are critically needed. Progress towards the clinical acceptance of pancreas and islet transplantation has been hampered by the lack of clear definitions of functional and efficacy outcomes, as well as a lack of consistently applied glycaemic control metrics, together with poor alignment with the field of artificial insulin delivery/artificial pancreas development. To address this problem, the International Pancreas & Islet Transplant Association (IPITA) collaborated with the European Pancreas and Islet Transplant Association (EPITA) to develop a consensus for a joint statement on the definition of function and failure of beta cell replacement therapies, which is summarised in this commentary.

Originele taal-2Engels
Pagina's (van-tot)1273-1276
Aantal pagina's4
TijdschriftDiabetologia
Volume61
Nummer van het tijdschrift6
DOI's
StatusGepubliceerd - jun 2018

Vingerafdruk

Duik in de onderzoeksthema's van 'Defining outcomes for beta cell replacement therapy: a work in progress'. Samen vormen ze een unieke vingerafdruk.

Citeer dit